People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

In D’Iberville, those battling Parkinson’s Disease are slipping on the gloves and fighting back thanks to SAAD Healthcare’s ...

Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...